Clinical impact of effective HCV DAAs: referrals for liver transplant drop after their introduction
France approves PrEP
Study reveals potential challenges for scaling up of HCV therapy in UK
Liver fibrosis improves after successful treatment for hepatitis C
Widely-used anti-alcoholism drug wakes up dormant HIV-infected cells
Daclatasvir plus sofosbuvir works well for people with genotype 3 hepatitis C and advanced liver disease in real-world clinical practice
Daclatasvir and sofosbuvir with ribavirin cures 90% of people with genotype 3 hepatitis C
Tenofovir during pregnancy reduces risk of mother-to-child hepatitis B virus transmission
